CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$7.52B
(+19%)
Cap. Flow
+$816M
Cap. Flow
% of AUM
10.85%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
$78.9M |
| 2 |
Biogen
BIIB
|
$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$63.8M |
| 4 |
Merck
MRK
|
$58M |
| 5 |
Gilead Sciences
GILD
|
$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$26.1M |
| 2 |
iRobot
IRBT
|
$15.5M |
| 3 |
Quest Diagnostics
DGX
|
$15.1M |
| 4 |
Colgate-Palmolive
CL
|
$14.9M |
| 5 |
Philip Morris
PM
|
$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Incyte
INCY
$17B
| $21.8M | 0.29% |
315,795
+18,935
| +6% | +$1.31M |
|
77
Chevron
CVX
$318B
| $21.4M | 0.28% |
174,939
+80,783
| +86% | +$9.88M |
|
78
Humana
HUM
$37.5B
| $21.1M | 0.28% |
62,394
-11,314
| -15% | -$3.83M |
|
|
ARRY
79
DELISTED
Array Biopharma Inc
ARRY
| $20.5M | 0.27% |
1,351,188
+601,300
| +80% | +$9.14M |
|
|
WUBA
80
DELISTED
58.COM INC
WUBA
| $20.4M | 0.27% |
277,500
-83,500
| -23% | -$6.15M |
|
81
TSMC
TSM
$1.2T
| $20.4M | 0.27% |
461,883
+394,583
| +586% | +$17.4M |
|
82
Estee Lauder
EL
$33.1B
| $20.3M | 0.27% |
139,604
+42,003
| +43% | +$6.1M |
|
83
HCA Healthcare
HCA
$95.4B
| $20.2M | 0.27% |
145,495
+23,899
| +20% | +$3.32M |
|
|
AET
84
DELISTED
Aetna Inc
AET
| $20.2M | 0.27% |
99,773
+44,502
| +81% | +$9.03M |
|
85
Alnylam Pharmaceuticals
ALNY
$58.6B
| $20.2M | 0.27% |
231,210
+112,500
| +95% | +$9.85M |
|
|
AERI
86
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $20.1M | 0.27% |
326,800
+205,100
| +169% | +$12.6M |
|
87
Caterpillar
CAT
$194B
| $19.9M | 0.26% |
130,381
+61,609
| +90% | +$9.39M |
|
88
Sarepta Therapeutics
SRPT
$1.98B
| $19.9M | 0.26% |
123,100
+64,100
| +109% | +$10.4M |
|
89
United Parcel Service
UPS
$72.3B
| $19.8M | 0.26% |
169,951
+92,683
| +120% | +$10.8M |
|
|
HES
90
DELISTED
Hess
HES
| $19.7M | 0.26% |
275,352
+42,791
| +18% | +$3.06M |
|
91
MetLife
MET
$53.6B
| $19.7M | 0.26% |
421,431
+47,269
| +13% | +$2.21M |
|
|
SAGE
92
DELISTED
Sage Therapeutics
SAGE
| $19.5M | 0.26% |
137,800
+81,400
| +144% | +$11.5M |
|
93
Thermo Fisher Scientific
TMO
$183B
| $19.4M | 0.26% |
79,618
+22,488
| +39% | +$5.49M |
|
94
PACCAR
PCAR
$50.5B
| $19.1M | 0.25% |
279,454
+72,371
| +35% | +$4.93M |
|
95
Palo Alto Networks
PANW
$128B
| $18.9M | 0.25% |
83,776
-26,551
| -24% | -$5.98M |
|
|
DFS
96
DELISTED
Discover Financial Services
DFS
| $18.7M | 0.25% |
244,761
-26,033
| -10% | -$1.99M |
|
97
Texas Instruments
TXN
$178B
| $18.5M | 0.25% |
172,475
-67,722
| -28% | -$7.27M |
|
98
Karyopharm Therapeutics
KPTI
$61.4M
| $18.5M | 0.25% |
1,085,500
+593,500
| +121% | +$10.1M |
|
99
Neurocrine Biosciences
NBIX
$13.5B
| $18.5M | 0.25% |
150,069
+69,969
| +87% | +$8.6M |
|
|
SPLK
100
DELISTED
Splunk Inc
SPLK
| $18.4M | 0.25% |
152,428
+42,484
| +39% | +$5.14M |
|